High Dose Omega 3 in People at Risk for Dementia

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2020

Conditions
DementiaInflammationMild Cognitive ImpairmentCognitive DeclineSCDCognitive DysfunctionPathologic ProcessesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisorderCognition Disorders
Interventions
DIETARY_SUPPLEMENT

Omega-3 capsules

BASF AS is the developer of the gelatine capsules containing Omega-3 ethyl ester from fish oil concentrate, as the dietary (nutritional) ingredient. The additional capsule fill ingredients are food additives permitted in food supplements according to Regulation (EC) No 1333/2008 on Food additives.

DIETARY_SUPPLEMENT

Olive oil

Soft gelatine capsule containing 1000 mg olive oil, refined.

Trial Locations (1)

1478

RECRUITING

Akershus university hospital, Sykehusveien 25, Lørenskog

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BASF AS

INDUSTRY

collaborator

Pre Diagnostics AS

UNKNOWN

lead

University Hospital, Akershus

OTHER